CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$0.69
+0.09 (+14.03%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.60M | 17.28M | 16.86M |
| Net Income | 2.07M | 2.55M | 2.09M |
| EPS | — | — | — |
| Profit Margin | 11.8% | 14.8% | 12.4% |
| Rev Growth | +11.2% | +9.6% | +9.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 13.16M | 11.55M | 14.29M |
| Total Equity | 23.94M | 21.43M | 24.65M |
| D/E Ratio | 0.55 | 0.54 | 0.58 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 4.18M | 3.81M | 3.82M |
| Free Cash Flow | 1.52M | 982.4K | 1.03M |